BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17485498)

  • 1. Pharmacokinetics of the anti-human immunodeficiency virus agent 1-(beta-D-dioxolane)thymine in rhesus monkeys.
    Asif G; Hurwitz SJ; Obikhod A; Delinsky D; Narayanasamy J; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2424-9. PubMed ID: 17485498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the antiviral agent beta-D-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine in rhesus monkeys.
    Ma L; Hurwitz SJ; Shi J; Mcatee JJ; Liotta DC; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 1999 Feb; 43(2):381-4. PubMed ID: 9925539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of (-)-beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys.
    Chen H; Schinazi RF; Rajagopalan P; Gao Z; Chu CK; McClure HM; Boudinot FD
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1625-30. PubMed ID: 10606085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys.
    Chen H; Boudinot FD; Chu CK; Mcclure HM; Schinazi RF
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2332-6. PubMed ID: 8891140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoramidate prodrugs of (-)-β-D-(2R,4R)-dioxolane-thymine (DOT) as potent anti-HIV agents.
    Wang P; Rachakonda S; Zennou V; Keilman M; Niu C; Bao D; Ross BS; Furman PA; Otto MJ; Sofia MJ
    Antivir Chem Chemother; 2012 May; 22(5):217-38. PubMed ID: 22358223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.
    Chen H; Pai SB; Hurwitz SJ; Chu CK; Glazkova Y; McClure HM; Feitelson M; Schinazi RF
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1922-8. PubMed ID: 12760868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity.
    Liang Y; Narayanasamy J; Rapp KL; Schinazi RF; Chu CK
    Antivir Chem Chemother; 2006; 17(6):321-9. PubMed ID: 17249246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
    Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-O-Aliphatic and amino acid ester prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine (DOT): synthesis, anti-HIV activity, cytotoxicity and stability studies.
    Liang Y; Sharon A; Grier JP; Rapp KL; Schinazi RF; Chu CK
    Bioorg Med Chem; 2009 Feb; 17(3):1404-9. PubMed ID: 19153047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus.
    Frick LW; Lambe CU; St John L; Taylor LC; Nelson DJ
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2722-9. PubMed ID: 7695253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.
    Cretton EM; Zhou Z; Kidd LB; McClure HM; Kaul S; Hitchcock MJ; Sommadossi JP
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1816-25. PubMed ID: 8239589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.
    Kerb R; Brockmöller J; Staffeldt B; Ploch M; Roots I
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2087-93. PubMed ID: 8878586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats.
    Kong XB; Vidal P; Tong WP; Chiang J; Gloff CA; Chou TC
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1472-7. PubMed ID: 1510443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys.
    Schinazi RF; Boudinot FD; Doshi KJ; McClure HM
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1214-9. PubMed ID: 2168144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane, and their metabolite (-)-beta-D-dioxolane guanine in monkey serum, urine and cerebrospinal fluid.
    Chen H; Manouilov KK; Chu CK; Schinazi RF; McClure HM; Boudinot FD
    J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):425-32. PubMed ID: 9174280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of (-)-beta-D-2,6-diaminopurine dioxolane and its metabolite, dioxolane guanosine, using ultraviolet and on-line radiochemical detection.
    Rajagopalan P; Gao Z; Chu CK; Schinazi RF; McClure HM; Boudinot FD
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):119-24. PubMed ID: 8590923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma pharmacokinetics and urinary and biliary excretion of a new potent tripeptide HIV-1 protease inhibitor, KNI-272, in rats after intravenous administration.
    Kiriyama A; Fujita K; Takemura S; Kuramoto H; Kiso Y; Takada K
    Biopharm Drug Dispos; 1994 Oct; 15(7):617-26. PubMed ID: 7849237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the antiviral agent beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Shi J; Hernandez-Santiago BI; Schinazi RF
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2877-82. PubMed ID: 17562805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.